Healthcare Provider Partnerships & Payments
Health Care Provider Partnerships & Payments
Importance of Collaboration for Patients
At Allergan, we believe scientific exchange between health care manufacturers and health care providers, including health care institutions, physicians and patient advocacy groups, is essential to the advancement of medicine and quality of patient care.
As such, we believe in ongoing engagement with all groups of health care providers to provide medical expertise and insights to Allergan and in building alliances with advocacy organizations whose mission is to educate and better patients. We believe that together we can discover meaningful innovation, educate other health care providers, or address significant unmet needs affecting patients.
We also believe in the need to recognize and provide appropriate funding and sponsorship for unmet educational and patient needs. We consider medical education grants of key importance in enabling scientific exchange and progressing scientific innovation and experience. And, we are equally as committed to making charitable contributions to causes in desperate need of support and recognition.
Allergan is supportive and committed to a full disclosure of its appropriate financial compensation to health care institutions and providers for all types of engagements.
Affordable Care Act
On February 8, 2013, the Centers for Medicare and Medicaid Services (CMS) published the final rule to implement section 6002 of the Affordable Care Act, which CMS calls the “National Physician Payment Transparency Program: OPEN PAYMENTS”. This is also commonly known as the “Sunshine Act”.
This final rule requires pharmaceutical and medical device manufacturers to report to CMS payments and transfers of value made to:
- Physicians licensed in the United States
- A specific list of teaching hospitals as designated by CMS
As of August 1, 2013, in order to comply with this new regulation, Allergan captures all payments and other transfers of value made to physicians and teaching hospitals. In addition, these payments and other transfers of value will be submitted to CMS by March 31 of each year.
Examples of payment types and other transfers of value Allergan will be tracking and submitting include:
- Educational materials
- Compensation for services other than consulting
- Research Royalties and licenses
- Business meals and business travel
CMS intends to make this information publicly available on an annual basis. The 2013 data will be made available as of September 30, 2014; and data for 2014 and beyond is scheduled to be made publicly available by June 30 of each subsequent year.
CMS has established a public website called “OPEN PAYMENTS”, which can be viewed at: http://go.cms.gov/openpayments. This website provides helpful information about the program.
Allergan Customer Support
Please contact Allergan Customer Support to address specific questions:
9:00AM - 5:30PM (Central Time)